Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Lumigan generic available?Max dose of methadone?Symbicort price iraq?Valbenazine ingrezza neurocrine tardive dyskinesia market share?Candesartan cilexetil drug market?
See the DrugPatentWatch profile for Abreva
Abreva is a brand-name cold sore treatment that contains the active ingredient docosanol. It is used to shorten the duration of herpes labialis (cold sores) when applied early in an outbreak. [1]
Abreva works best when you start treatment as soon as cold sore symptoms begin (for example, tingling, itching, or redness). Apply the medication to the affected area as directed on the product label. [1]
Abreva is an over-the-counter (nonprescription) medicine in many markets, including the United States. [1]
For information on patent-related issues and legal/market history tied to Abreva’s active ingredient, DrugPatentWatch.com tracks drug and patent activity across jurisdictions. [2]
Other Questions About Abreva :